ADRX Andrx

Andrx Corporation (Nasdaq:ADRX) is scheduled to present on Tuesday, February 7, 2006, at 3:20 p.m. ET at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference, at the Grand Hyatt in New York City. Angelo C. Malahias, Andrx Corporation's President, will present on behalf of the Company and, accompanied by Larry Rosenthal, President of Andrx Pharmaceuticals, Inc., Andrx's generic business, will address questions from the audience. The presentation and question and answer session will be webcast live on the Internet at the following web address: http://www.wsw.com/webcast/ml53/adrx/. A replay of the presentation will be available approximately three hours after the broadcast and will be available until February 21, 2006. It may be accessed through the same web address. A link to the broadcast, along with the slides for this presentation, will be available on Andrx's website at: http://www.andrx.com. About Andrx Corporation We are a pharmaceutical company that: -- develops, manufactures and commercializes generic versions of controlled-release, niche and immediate-release pharmaceutical products, including oral contraceptives; -- distributes pharmaceutical products, primarily generics, which have been commercialized by others, as well as our own, primarily to independent pharmacies, pharmacy chains and physicians' offices; and -- develops and manufactures pharmaceutical products for other pharmaceutical companies, including combination products and controlled-release formulations utilizing our patented technologies and formulation capabilities. This release and additional information about Andrx Corporation is also available on the Internet at: http://www.andrx.com.